Sr One Capital Management, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 12, 2026, Sr One Capital Management, Lp disclosed 15 stock positions valued at approximately $1.04B as of quarter-end June 30, 2026. The largest holdings include Veradermics, Inc., Zenas BioPharma, Inc, and CRISPR Therapeutics AG.
- Report Period
- June 30, 2026
- No. of Stocks
- 15
- Portfolio Value
- $1.04B
Holdings by Sector
Sr One Capital Management, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Veradermics, Inc. | MANE | Healthcare | 28.42% | 2,401,868 | - | - | $295,285,652 |
| Zenas BioPharma, Inc | ZBIO | Healthcare | 12.31% | 5,037,854 | - | - | $127,860,735 |
| CRISPR Therapeutics AG | CRSP | Healthcare | 10.70% | 2,038,763 | - | - | $111,194,134 |
| Avalyn Pharma, Inc | AVLN | Healthcare | 10.48% | 3,308,649 | +3,308,649 | +100.00% | $108,920,725 |
| Design Therapeutics, Inc. | DSGN | Healthcare | 9.09% | 6,526,476 | - | - | $94,438,108 |
| Odyssey Therapeutics, Inc. | ODTX | Healthcare | 6.83% | 3,794,883 | +3,794,883 | +100.00% | $71,002,261 |
| Alumis Inc. | ALMS | Healthcare | 5.31% | 1,959,896 | - | - | $55,151,473 |
| ORIC Pharmaceuticals, Inc. | ORIC | Healthcare | 4.81% | 4,615,384 | +100,455 | +2.22% | $49,984,609 |
| Mineralys Therapeutics Inc. | MLYS | Healthcare | 4.06% | 1,563,966 | - | - | $42,195,803 |
| ARS Pharmaceuticals, Inc. | SPRY | Healthcare | 3.09% | 4,012,903 | - | - | $32,143,353 |
| Mobia Medical, Inc | MOBI | Healthcare | 2.56% | 1,986,072 | +1,986,072 | +100.00% | $26,613,365 |
| Nkarta, Inc. | NKTX | Healthcare | 0.91% | 3,333,333 | - | - | $9,433,332 |
| Oculis Holding AG | OCS | Healthcare | 0.86% | 641,022 | - | - | $8,890,975 |
| Ultragenyx Pharmaceutical Inc. | RARE | Healthcare | 0.44% | 137,753 | - | - | $4,599,573 |
| enGene Holdings Inc. | ENGN | Healthcare | 0.12% | 747,750 | - | - | $1,293,607 |
Showing 15 of 15 holdings in the latest reporting period.